RESUMO
This study investigates the decision process of own-brand intrusion by contract manufacturers and their selection of invasion sales modes under the consideration of service quality disparities between brand manufacturers and contract manufacturers. Specifically, the study constructs a three-tier supply chain system comprising a brand manufacturer, a contract manufacturer, and an e-commerce platform. The equilibrium profits under different sales mode combinations are determined by using reverse induction methodology, and the optimal sales mode combinations are analyzed and compared. The study reveals that the decision process of contract manufacturers' own-brand invasion depends on the potential market demand. Furthermore, when brand manufacturers adopt the reselling mode, the service quality level does not affect the decision process of invasion sales modes. However, when brand manufacturers adopt the agency mode, contract manufacturers with low service quality levels are more suitable for invasion through the agency mode, whereas contract manufacturers with high service quality levels are better suited for invasion through the reselling mode. Additionally, for the equilibrium sales mode combination among members of the supply chain, it is observed that with lower commission rates, both brand manufacturers and contract manufacturers choose the agency mode, while with higher commission rates, both choose the reselling mode. When commission rates are moderate, brand manufacturers prefer the agency mode, whereas contract manufacturers prefer the reselling mode.
Assuntos
Comércio , Contratos , Comércio/métodosRESUMO
In this paper, we propose a novel method of automatic sleep stage classification based on single-channel electroencephalography (EEG). First, we use marginal Hilbert spectrum (MHS) to depict time-frequency domain features of five sleep stages of 30-second (30s) EEG epochs. Second, the extracted MHSs features are input to a convolutional neural network (CNN) as multi-channel sequences for the sleep stage classification task. Third, a focal loss function is introduced into the CNN classifier to alleviate the classes imbalance problem of sleep data. Experimental results show that the proposed method can obtain an overall accuracy of 86.14% on the public Sleep-EDF dataset, which is competitive and worth exploring among a series of deep learning methods for the automatic sleep stage classification task.
Assuntos
Redes Neurais de Computação , Fases do Sono , Eletroencefalografia , Humanos , SonoRESUMO
Nowadays, cancer has become a major threat to people's lives and health. Convolutional neural network (CNN) has been used for cancer early identification, which cannot achieve the desired results in some cases, such as images with affine transformation. Due to robustness to rotation and affine transformation, capsule network can effectively solve this problem of CNN and achieve the expected performance with less training data, which are very important for medical image analysis. In this paper, an enhanced capsule network is proposed for medical image classification. For the proposed capsule network, the feature decomposition module and multi-scale feature extraction module are introduced into the basic capsule network. The feature decomposition module is presented to extract richer features, which reduces the amount of calculation and speeds up the network convergence. The multi-scale feature extraction module is used to extract important information in the low-level capsules, which guarantees the extracted features to be transmitted to the high-level capsules. The proposed capsule network was applied on PatchCamelyon (PCam) dataset. Experimental results show that it can obtain good performance for medical image classification task, which provides good inspiration for other image classification tasks.
Assuntos
Diagnóstico por Imagem , Redes Neurais de ComputaçãoRESUMO
OBJECTIVE: To investigate the clinical characteristics, diagnosis and treatment methods of patients with myeloid sarcoma(MS)ï¼ Methods: The clinical data, laboratory examination, clinical pathology and treatment methods of 15 patients with MS treated in the First Affiliated Hospital of Wannan Medical College from June 2012 to January 2020 were retrospectively analyzed. RESULTS: Among the 15 cases of MS, including eight males and seven females, the middle age of patients were 53ï¼19 to 72ï¼. Among the 15 patients with MS, 4 showed solitary MS, while 11 showed secondary MS. Immunohistochemical results showed that MPO+ï¼12/15ï¼ãCD68+ï¼3/6ï¼ãLys+ï¼3/3ï¼ãCD34+ï¼6/14ï¼ãTdT+ï¼0/9ï¼ãCD43+ï¼13/13ï¼ãCD117+ï¼6/10ï¼ãCD15+ï¼7/10ï¼ãCD3+ï¼1/15ï¼ãCD20+ï¼0/15ï¼. 6 of 13 patients were survival till follow-up dateï¼The median overall survival (OS) time was 16 months (1-88 months)ï¼Conclusion: Myeloid sarcoma is rare and often secondary from acute myeloid leukemia(AML) and chronic myeogenous leukemia(CML). Isolated MS can easily be misdiagnosed as lymphoma. Treatment response should be evaluated in combination with bone marrow examination, PET/CT and other imaginesï¼Systematic chemotherapy and hematopoietic stem cell transplantation are the main method to treat MS.
Assuntos
Transplante de Células-Tronco Hematopoéticas , Leucemia Mieloide Aguda , Sarcoma Mieloide , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Estudos RetrospectivosRESUMO
OBJECTIVE: To investigate the clinical characteristics of primary cutaneous Î³Δ T cell lymphoma and its treatment methods. METHODS: The clinical data and treatment process of one woman case of primary cutaneous γ Δ T cell lymphoma diagnosed in our department were analysed. The multiple subcutaneous nodules were the main clinical features, the diagnosis of primary cutaneous Î³Δ T cell lymphoma was comfired by skin biopsy pathology. The immunophenotypes of lymphocytes showed CD20-, CD3+, CD4-, CD8-, CD56+, TIA-1+, Ki-67+ (about 60%); plasma cells kappa+(part)/lambda predominate+(part); histocytes CD4+, CD68/PGM1+; ßF1-, epstein-barr (EB) virus showed negative EBER in situ hybridization. RESULTS: By means of the chemotherapy regimens containing L-Asparaginase, the complete remission (CR) was achieved. Then, the patients were given autologous hematopoietic stem cell transplantation. Neutrophils were implanted after 16 days, and platelet was implanted after 18 days. Now, the patient is still in remission. CONCLUSION: primary cutaneous Î³Δ T cell lymphoma is rare and easy to be misdiagnosed. This disease is aggressive and its prognosis is poor. The large dose chemotherapy with L-asparaginase shows a certain curative efficacy, the autologous hematopoietic stem cells can prolong survival time of the patient.
Assuntos
Transplante de Células-Tronco Hematopoéticas , Linfoma Cutâneo de Células T/terapia , Asparaginase/uso terapêutico , Feminino , Herpesvirus Humano 4/isolamento & purificação , Humanos , Imunofenotipagem , Indução de Remissão , Transplante AutólogoRESUMO
OBJECTIVE: To investigate the distribution of pathogenic bacteria in the patients with hematologic malignancies received hematopoietic stem cell transplantation (HSCT) and its influence on the expression of BCL-2 and BAX proteins. METHODS: The clinical data of 64 patients with malignant lymphoma (ML) received auto-HSCT from January 2011 to December 2015 in our hospital were analyzed. On basis of post-treansplant infection, the patients were divided into infection group (36 cases) and non-infection group (28 cases). The distribution of pathogenic bacteria in 2 groups was identified, the T lymphocyte subsets of peripheral blood, expression level of apoptotic proteins and C-reaction protein (CRP) in 2 group were detected. RESULTS: Thirty-six strains of pathogenic bacteria were isolated from 36 case of hematological malignancy after HSCT, including 24 strains of Gram-negative bacteria (66.67%) with predominamce of klebsiella pneumoniae (19.44%). The periperal blood CD4+ (t=2.637, P<0.01), CD4+/CD8+ ratio (t=8.223, P<0.01), BCL-2 protein (t=5.852, P<0.05), BCL-2/BAX ratio (t=14.56, P<0.01) in infection group were significantly lower than those in non-infection group, while CD8+ (t=2.285, P=<0.01), CRP (t=39.71, P<0.01), BAX level in infection group were higher than those in non-infection group. The pearson correcation analysis showed that the CD4+/CD8+ ratio in infection group positively correlated with BCL-2/BAX ratio (t=0.341, P<0.05), while serum CRP level in infection group negatively correlated with BCL-2/BAX ratio (t=-0.362, P<0.05). CONCLUSION: The pathogenic bacteria infecting ML patients after HSCT were mainly Gram-negative bacteria. The post-transplant infection can promote the expression up-regulation of related inflammatory factors and apoptotic proteins. The pathogens may be involved in cell apoptisis that provides a new strategy to treat the hematologic malignancies.
Assuntos
Bactérias Gram-Negativas/isolamento & purificação , Neoplasias Hematológicas/microbiologia , Transplante de Células-Tronco Hematopoéticas , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína X Associada a bcl-2/metabolismo , Proteína C-Reativa/análise , Relação CD4-CD8 , Neoplasias Hematológicas/metabolismo , Humanos , Subpopulações de Linfócitos T/citologia , Regulação para CimaRESUMO
Patients with relapsed or refractory acute myeloid leukemia (rAML) have a poor prognosis if they do not undergo hematopoietic stem cell transplantation (HSCT). We describe a case herein of acute myeloid leukemia (AML) with monosomy 7 and EVI1(+)(-7/EVI1(+)) in a patient who failed to achieve a complete remission (CR) after two cycles of standard induction chemotherapy. He subsequently received decitabine (DAC) as "bridge therapy" and directly underwent unrelated cord blood transplantation (UCBT) due to the absence of an available sibling donor. Although DAC treatment did not induce CR, it did produce hematologic improvement and control disease progression with acceptable side effects, thus effectively bridging the time of donor search. Following UCBT, the marrow showed complete hematologic and cytogenetic remission. At present, 18 months after the transplantation, the patient's general condition is still good.
Assuntos
Antimetabólitos Antineoplásicos/uso terapêutico , Azacitidina/análogos & derivados , Transplante de Células-Tronco Hematopoéticas/métodos , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/terapia , Azacitidina/uso terapêutico , Deleção Cromossômica , Cromossomos Humanos Par 7 , Proteínas de Ligação a DNA/genética , Decitabina , Sangue Fetal/transplante , Humanos , Quimioterapia de Indução , Leucemia Mieloide Aguda/tratamento farmacológico , Proteína do Locus do Complexo MDS1 e EVI1 , Masculino , Proto-Oncogenes/genética , Fatores de Transcrição/genética , Transplante Homólogo/métodos , Resultado do Tratamento , Adulto JovemRESUMO
OBJECTIVE: To explore the clinical features, diagnosis and treatment of primary breast diffuse large B- cell lymphoma (PBDLBCL). METHODS: Clinical records of 9 PBDLBCL patients treated in Department of Hematology of Yijishan Hospital Affiliated to Wannan Medical College from August 2001 to January 2014 were analyzed retrospectively. RESULTS: All of the 9 patients were female, with an average age of 48 years (range 28 to 75), 8 cases had unilateral breast tumors and 1 case had bilateral. According to the Ann Arbor stage standard, 2 cases were of stage IE and 7 were IIE. None of them was concurrent with B symptoms; 6 cases had IPI (International prognostic Index) score 0 and 3 had score 1. 2 cases belonged to germinal center B cells type (GCB) and 7 belonged to non-GCB. Double-Hit lymphomas were presented in 3 cases. Out of 9 cases, 3 cases were diagnosed by using tubular needle biopsy, 5 cases were diagnosed by using resection of breast mass, and 1 case was diagnosed by using modified radical mastectomy. 1 case received radical mastectomy, 1 case received unilateral breast removal, 1 case gave up, 1 case received mass excision with chemotherapy and radiotherapy, 5 cases received mass excision with chemotherapy and 1 case received central prophylaxis. A complete response (CR) was observed in 6 cases after first-line chemotherapy. The median follow-up time was 18 months (range 0.1 to 150), 3 cases relapsed and 5 cases died. CONCLUSION: PBDLBCL mostly occurs in female. The main pathological type is non-GCB coupled with Double-Hit lymphoma. Tubular needle biopsy offers benifit in the diagnosis of PBL, R-CHOP or R-CHOP combined with chemotherapy/radiotherapy produce best outcome among all the treatments. Intrathecal injection of chemotherapy drugs may help to prevent recurrence of PBL central.